Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes

Kidney International

Volumn 51, Issue 1, 1997, Pages 222-229

  Fisher, Margaret ^a,c   Pusey, Charles D ^a   Vaughan, Robert W ^a   Rees, Andrew J ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c WAIKATO HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HLA DR ANTIGEN;

ALLELE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOPATHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031048603     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.27     Document Type: Article

References (41)

1. LERNER RA, GLASSOCK RJ, DIXON FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126:989-1004, 1967
2. KALLURI R, GUNWAR S, REEDERS ST, MORRISON KC, MARIYAMA M, EBNER KE, NOELKEN ME, HUDSON BG: Goodpusture syndrome. Localization of the epitope for the autoantibodies to the carboxyterminal region of the α3(IV) chain of basement membrane collagen. J Biol Chem 266:24018-24024, 1991
3. PUSEY CD, DASH A, KERSHAW MJ, MORGAN A, REILLY A, REES AJ, LOCKWOOD CM: A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane. Lab Invest 56:23-31, 1987
4. HELLMARK T, JOHANSSON C, WIESLANDER J: Characterisation of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int 46:823-829, 1994
5. DERRY CJ, LOMBARDI G, MASON PD, PUSEY CD: T cell responses to the Goodpasture antigen. Clin Exp Immunol 100:262, 1995
6. FISHER M, DERRY CJ, PUSEY CD, REES AJ: T cells proliferating to the Goodpasture antigen show preferential expression of T cell receptor variable beta chain genes. (abstract) J Am Soc Nephrol 5:747, 1994
7. REES AJ, PETERS DK, COMPSTON DA, BATCHELOR JR: Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome. Lancet 1:966-968, 1978
8. BODMER JG, MARSH SGE, ALBERT ED, BODMER WF, DUPONT B, ERLICH HA, MACH B, MAYR WR, PARHAM P, SASAZUKI T, SCREUDER GMTH, STROMINGER JL, SVEJGAARD A, TERASAKI PI: Nomenclature for factors of the HLA system, 1994. Eur J Immunogenet 21:485-517, 1994
9. BURNS AP, FISHER M, LI P, PUSEY CD, REES AJ: Molecular analysis of HLA Class II genes in Goodpasture's disease. Quart J Med 88:93-100, 1995
10. HUEY B, MCCORMACK K, CAPPER J, RATLIFF C, COLOMBE BW, GAROVOY MR, WILSON CB: Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization. Kidney Int 44:307-312, 1993
11. DUNCKLEY H, CHAPMAN JR, BURKE J, CHARLESWORTH J, HAYES J, HAYWOOD E, HUTCHISON B, IBELS L, KALOWSKI S, KINCAID-SMITH P, LAWRENCE S, LEWIS D, MORAN J, PUSSEL B, RESTIFO A, STEWART J, THATCHER G, WALKER R, WAUGH D, WILSON D, WYNDHAM R: HLA-DR and DQ genotyping in anti-GBM disease. Disease Markers 9:249-256, 1991
12. MERCIER B, BOURBIGOT B, RAGUENES O, RONDEAU E, SIMON P, LEGENDRE C, HURAULT DE LIGNY B, LANG P, MOURAD G, LEGRAND D, COVILLE P, FEREC C: HLA Class II typing of Goodpasture's syndrome affected patients. (abstract) J Am Soc Nephrol 3:658, 1992
13. AHARONI R, TEITELBAUM D, ARNON R, PURI J: Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature 351:147-150, 1991
14. ACHA-ORBEA H, MITCHELL DJ, TIMMERMAN L, WRAITH DC: Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263-273, 1988
15. BROWN JH, JARDETZKY TS, GORGA JC, STERN LJ, URBAN RG, STROMINGER JL, WILEY DC: Three-dimensional structure of the human class II histocopatibility antigen HLA-DR1. Nature 364:33-39, 1993
16. KATBAMNA I, TURNER N, ROSS CN, PUSEY CD: Development and application of an ELISA for Goodpasture's disease based on sheep α3(IV)NC1 domains. J Clin Lab Immunol 47:11-24, 1995
17. DERRY CJ, DUNN MJ, REES AJ, PUSEY CD: Restricted specificity of the autoantibody response in Goodpasture's syndrome demonstrated by two-dimensional Western blotting. Clin Exp Immunol 86:457-463, 1991
18. SAMBROOK J, FRITSCH EF, MANIATIS T: Molecular Cloning: A Laboratory Manual (2nd ed). New York, Cold Spring Harbor Laboratory Press, 1989
19. KIMURA A, SASAZUKI T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique, in Proceedings of the Eleventh International Histocompatibility Workshop and Conference, edited by TSUJI K, AIZAWA M, SASAZUKI T, Oxford, Oxford University Press, 1992, p 397
20. WOOD WI, GITSCHIER J, LASKY LA, LAWN RM: Base composition-independent hybridization in tetramethylammonium chloride: A method for oligonucleotide screening of highly complex gene libraries. PNAS 82:1585-1588, 1985
21. TIERCY JM, JEANNET M, MACH B: Oligonucleotide typing analysis for the linkage disequilibrium between the polymorphic DRB1 and DRB5 loci in DR2 haplotypes. Tissue Antigens 37:161-164, 1991
22. DOHERTY DG, VAUGHAN RW, DONALDSON PT, MOWAT AP: HLA DQA, DQB, and DRb genotyping by oligonucleotide analysis: Distribution of alleles and haplotypes in British Caucasoids. Hum Immunol 34:53-63, 1992
23. ALTMAN DA: Practical Statistics for Medical Research. London, Chapman and Hall, 1991, p 268
24. PAYAMI H, JOE S, FARID NR, STENSZKY V, CHAN SH, YEO PPB, CHEAH JS, THOMSON G: Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 45:541-546, 1989
25. BOWMAN SJ, SIVAKUMARAN M, SNOWDEN N, BHAVNANI M, HALL MA, PANAYI GS, LANCHBURY JS: The large granular lymphocyte syndrome with rheumatoid arthritis. Arthritis Rheum 37:1326-1330, 1994
26. BEGOVICH AB, MCCLURE GR, SURAJ VC, HELMUTH RC, FILDES N, BUGAWAN TL, ERLICH HA, KLITZ W: Polymorphism, recombination, and linkage disequilibrium within the HLA Class II region. J Immunol 148:249-258, 1992
27. COHEN N, BRAUTBAR C, FONT M-P, DAUSSET J, COHEN D: HLA-DR2-associated Dw subtypes correlate with RFLP clusters: Most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23:84-89, 1986
28. PAUL C, SCHOENWALD U, TRUCKENBRODT H, BETTINOTTI MP, BRUNNLER G, KELLER E, NEVINNY-STICKEL C, YAO Z, ALBERT ED: HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 37:442-448, 1993
29. STERN LJ, BROWN JH, JARDETZKY TS, GORGA JC, URBAN RG, STROMINGER JL, WILEY DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221, 1994
30. REICH E-P, SHERWIN RS, KANAGAWA O, JANEWAY CA: An explanation for the protective effect of the MHC Class II I-E molecule in murine diabetes. Nature 341:326-328, 1989
31. SINIGAGLIA F, HAMMER J: Defining rules for the peptide-MHC class II interaction. Curr Opin Immunology 6:52-56, 1994
32. FU X-T, BONO CP, WOULFE SL, SWEARINGEN C, SUMMERS NL, SINIGAGLIA F, SETTE A, SCHWARTZ BD, KARR RW: Pocket 4 of the HLA-DR(α,α1*0401) molecule is a major determinant of T cell recogition of peptide. J Exp Med 181:915-926, 1995
33. VOGT AB, KROPSHOFER H, KALBACHER H, KALBUS M, RAMMENSEE H-G, COLIGAN JE, MARTIN R: Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 153:1665-1673, 1994
34. DAVIES JL, KAWAGUCHI Y, BENNETT ST, COPEMAN JB, CORDELL HJ, PRITCHARD LE, REED PW, GOUGH SCL, JENKINS SC, PALMER SM, BALFOUR KM, ROWE BR, FARRALL M, BARNETT AH, BAIN SC, TODD JA: A genome-wide search for human type I diabetes susceptibility genes. Nature 371:130-136, 1994
35. REES AJ, PETERS DK, AMOS N, WELSH KI, BATCHELOR JR: The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int 26:445-450, 1984
36. JACOB CO, FRONEK Z, LEWIS GD, KOO M, HANSEN JA, MCDEVITT HO: Heritable major histocompatiblity complex Class II-associated differences in production of tumour necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosis. PNAS 87:1233-1237, 1990
37. TURNER N, MASON PJ, BROWN R, FOX M, POVEY S, REES AJ, PUSEY CD: Molecular cloning of the human Goodpasture antigen demonstrates it to be the α3 chain of type IV collagen. J Clin Invest 89:592-601, 1992
38. TURNER N, FORSTOVA J, REES A, PUSEY CD, MASON PJ: Production and characterization of recombinant Goodpasture antigen in insect cells. J Biol Chem 269:17141-17145, 1994
39. FUGGER L, MICHIE SA, RULIFSON I, LOCK CB, MCDEVITT GS: Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. PNAS 91:6151-6155, 1994
40. PHELPS R, TURNER AN, REES AJ: Elution of antigen specific peptides from HLA-DR15 molecules purified from antigen presenting cells. J Biol Chem (in press)
41. GAUR A, FATHMAN CG: Immunotherapeutic strategies directed at the trimolecular complex. Adv Immunol 56:219-265, 1994